Literature DB >> 1090666

Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).

R E Rocklin.   

Abstract

Leukocyte inhibitory factor (LIF) obtained from normal human lymphocytes stimulated by Concanavalin A was characterized by Sephadex gel filtration, disc electrophoresis, isopycnic centrifugation, enzymatic treatment and by immunoabsorbent studies. LIF activity was found after Sephadex G-100 gel filtration in a fraction containing molecules having the size of albumin (68,000 daltons). This is the same region were LIF activity derived from antigen-stimulated lymphocytes has previously been found to elute. On disc gel electrophoresis at pH 9.1, peak LIF activity was eluted from the acrylamide gel fraction containing molecules that migrate with albumin. In isopycnic centrifugation studies, human LIF was shown to have a buoyant density similar to that of pure protein. Human LIF was inactivated by treatment with chymotrypsin but not by neuraminidase treatment. LIF activity could not be removed by incubating the material on columns containing Sepharose 6b coupled with anti-human serum albumin or anti-Fab. The characteristics of human LIF and migration inhibitory factor were compared.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090666

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Physiological studies with human leukocyte inhibitory factor.

Authors:  L C Borish; R E Rocklin
Journal:  Surv Immunol Res       Date:  1985

2.  Dependence of lymphocyte surface Ig on continuous polyclonal activation.

Authors:  D M Bucholz; S Dray; M Teodorescu
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

3.  Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.

Authors:  A J Górski; B Dupont; J A Hansen; R O'Reilly; E Smithwick; R Górska; R A Good
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.

Authors:  M Hirashima; K Tashiro; H Hayashi
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

5.  A chemotactic inhibitor in synovial fluid.

Authors:  Y Matzner; R E Partridge; B M Babior
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

6.  Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.

Authors:  D H Meshulam; H E Blair; B L Wong; S Charm; J Minowada; R E Rocklin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Mononuclear cells from patients with the hyperimmunoglobulin E-recurrent infection syndrome produce an inhibitor of leukocyte chemotaxis.

Authors:  H Donabedian; J I Gallin
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

8.  The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.

Authors:  R Lomnitzer; A Glover; A R Rabson
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

9.  Role of ions and extracellular protein in leukocyte motility and membrane ruffling.

Authors:  C Mukherjee; W S Lynn
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

10.  Albumin associated with purified pig lymphocyte plasma membrane.

Authors:  M J Owen; B H Barber; R A Faulkes; M J Crumpton
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.